ArticleCancer science2016

Metformin inhibits the prometastatic effect of sorafenib in hepatocellular carcinoma by upregulating the expression of TIP30.

Zhigui Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.